rosurgeons and plastic surgeons performing complicated cranioplasties, we describe a novel yet simple technique for scalp tissue expansion that offers excellent and reproducible aesthetic outcomes with low associated morbidity.
methods
With approval from the Henry Ford Hospital Institutional Review Board, we searched our patient database and identified patients who had undergone definitive cranioplasty with preoperative scalp tissue expansion using the DermaClose RC device (Wound Care Technologies Inc.; http://dermaclose.com/). Electronic medical records were searched to gather patient demographic data, including age, sex, primary pathology, number of craniotomies and/or craniectomies, history of radiation therapy, duration of external scalp tissue expansion, and patient discomfort level after application of the DermaClose RC device. Patient charts were analyzed for structural success rates as well as complications related to the definitive cranioplasty.
Only patients with a history of multiple (≥ 3) craniotomies and/or craniectomies with associated complicating factors, such as prior cranial radiation or recalcitrant scalp infections, were considered candidates for DermaClose RC device application. In all cases, the neurosurgeon and the plastic surgeon concurred that significant tissue scarring and scalp atrophy necessitated tissue expansion to ensure tension-free skin closure. All patients underwent delayed placement of the DermaClose RC tissue expander device by a plastic surgeon, either in the outpatient setting or in the operating room under local anesthesia.
technique
The DermaClose RC has 10 anchors that pierce the dermis with traction clips, which are then secured with staples. These anchors, which the traction line tabs set approximately 1 cm outside the bone defect margin, are spaced circumferentially around the cranial defect. A tension controller is then sutured to the scalp in a position that will not inhibit the patient's favorite sleeping position. Next, the tension line is placed circumferentially through the tension line tabs of each anchor. A tension line placed circumferentially rather than in a crisscrossing pattern usually conforms more naturally to the curved scalp. The underlying skin is protected by placing customized, longitudinally slit plastic tubes over the tension lines (Fig. 1) .
On average, the DermaClose RC device was applied to patients 238 days (SD ± 60 days) after their last craniectomy, when maximal scalp tissue retraction had occurred. All patients were clinically deemed to be appropriate candidates for rotational flaps with or without skin grafts. Over the course of 7-10 days, the plastic surgeon sequentially adjusted the device to apply constant tension to the scalp tissue, which facilitates tissue expansion to provide more skin surface area for definitive closure. 9 The DermaClose RC device automatically maintains tension below capillary filling pressure, which is 30 mm Hg.
surface area and scalp volume calculations
Thin-cut head CT scans were used in conjunction with computerized 3D rendering software to generate a 3D model of each patient's cranial soft tissues and defect ( Fig.  2A) . The thickness of soft tissue on each patient's contralateral skull, which is normally 4-6 mm, was then estimated on the CT scan (Fig. 2B) . Next, the initial implant, designed to mirror contralateral symmetry, was expanded in the external direction by the absolute value of the thickness of the soft tissue overlying the contralateral virgin skull. We then arbitrarily adjusted the tissue thickness subjacent to the implant (Fig. 2C ) such that this hybrid configuration snugly fit into the patient's original 3D defect model and produced a composite volume model (Fig.  2D) . By subtracting the composite volume model from the original 3D soft tissue model, the computer software was able to estimate the total expanded tissue surface area and volumes (Fig. 2E) .
To more accurately estimate the efficacy of the soft tissue expansion achieved with the application of the DermaClose RC device, we also calculated the scalp surface area prior to expansion (defective scalp surface area [DSSA]) by simply delineating the margins of the scalp around the cranial defect and allowing the computer software to automatically calculate the area within the curve. Because none of the patients underwent repeat CT imaging after application of the DermaClose RC device, information regarding the stretched scalp surface area after device appli- cation was extrapolated from the aforementioned volume model (Fig. 2D) [SSV] ) were calculated by extruding the surface area measurements described above and using the estimated thickness of the scalp soft tissue on the contralateral side. Using the measured DSSA and SSSA as well as the DSV and SSV, we were able to calculate percentage increases in scalp surface area and volume achieved by the DermaClose RC device All patients were maintained on low doses of oral narcotic-based analgesics (5-7.5 mg hydrocodone/acetaminophen, Norco) while undergoing scalp expansion. Once adequate scalp expansion was confirmed by the plastic surgeon, all patients underwent delayed but definitive cranioplasty ( Fig. 3 ) with a tension-free skin closure. A Jackson-Pratt drain was placed subgaleally in all patients to minimize fluid collection and reduce the risk of postoperative infection. A postoperative CT scan was obtained in every patient. All patients were discharged an average of 3.3 days (SD ± 2 days) after cranioplasty. No perioperative complications were encountered in any of the patients.
results
We performed cranioplasties in 6 patients, 5 female (83%) and 1 male (17%). Their ages ranged from 36 to 70 years, with an average age of 53.2 years (SD ± 13.9). The precranioplasty pathology was variable and included convexity meningioma (1 case), astrocytoma (2), ruptured arteriovenous malformation (1), suprasellar hemangiopericytoma (1), and traumatic intracerebral hemorrhage (1; Table  1 ). Application of the DermaClose RC device resulted in, on average, a 16% increase in the scalp surface area (range 6.57%-34.97%) or a 13% increase in the scalp volume (range 3.64%-29.57%; Table 2 ). All reconstructions were completed within 7-10 days after placement of the external tissue expander. None of the patients required extensive ro- tation flaps or skin grafts. All patients had adequate tissue for tension-free closure despite the increase in the cranial vault. The device was well tolerated, with all patients reporting pain scores ≤ 2 according to the visual analog scale for pain. 17 Short-and long-term follow-ups after cranial reconstruction revealed satisfactory wound closure and excellent cosmetic results in 100% of the patients. There were no cases of delayed wound closure, infection (including soft tissue, meningitis, or intracranial abscess formation), dermatitis, or cerebrospinal fluid leakage. All patients expressed satisfaction with their cosmetic outcome.
illustrative cases

Case 1
A 36-year-old female with history of 3 craniotomies for the resection of anaplastic astrocytoma, cosmetic methylmethacrylate cranioplasty, and external beam radiation therapy (EBRT) with concurrent chemotherapy underwent a fourth craniotomy for washout of subgaleal empyema and removal of a suspicious bone flap. After completing a course of antibiotics, the patient, while under local anesthesia, underwent delayed DermaClose RC device placement (180 days after bone flap removal) by a plastic surgeon in an operating room. Ten days after placement of the tissue expander, the patient underwent definitive cranioplasty without any complications. She was discharged to home 5 days after the reconstructive procedure. Followup 17 weeks after surgery revealed satisfactory wound closure and cosmetic results (Fig. 4) .
Case 2
A 63-year-old diabetic female with history of decompressive craniectomy for a ruptured arteriovenous malformation followed by delayed cranioplasty underwent multiple craniotomies for wound dehiscence and a second craniectomy for removal of an infected bone flap. After completing a rehabilitation course, the patient, while under local anesthesia, underwent placement of a DermaClose RC expander in an operating room (235 days after bone flap removal). Ten days after placement of the tissue expander, she underwent definitive cranioplasty and was discharged to home 4 days later. Follow-up 7 weeks after surgery revealed excellent cosmetic results and no infectious complications (Fig. 5) .
Case 3
A 67-year-old female with a history of 2 bifrontal craniotomies for the resection of suprasellar hemangiopericytoma followed by EBRT underwent a third craniectomy to remove the infected bone flap. After completing a course of antibiotics, the patient tolerated the placement of a DermaClose RC expander in the operating room while under local anesthesia (315 days after bone flap removal). Ten days after placement of the expander, she underwent definitive cranioplasty without complications. She was discharged to home 3 days after reconstructive surgery. Long-term follow-up 12 months after cranial reconstruction revealed excellent cosmetic results and no infectious stigmata (Fig. 6) .
discussion
There is archeological evidence that Incan surgeons were routinely performing trephinations of the cranium as early as 3000 BC and that a minority of their patients also underwent cranioplasties. However, not until the 16th century did Fallopius describe the first case of cranial reconstruction with a gold plate. 24 Almost a century later in 1668 in Amsterdam, van Meekeren successfully performed a cranioplasty using a dog's calvarial graft. 24 Since then, a multitude of materials and techniques have been used for cranial reconstruction. 27 Despite modern advances in aseptic and surgical techniques, cranial reconstruction remains a challenge for plastic surgeons and neurosurgeons alike. Reconstruction is especially difficult in patients with prior infections, cranial radiation, or a history of multiple craniotomies as the scalp will have been subject to significant scarring and contraction, making a procedure with a high morbidity (16.4%) 6 even more complicated. It is our practice to delay all routine cranial reconstructions for 3-6 months after the initial neurological injury to allow for optimal recovery and minimize the risk of perioperative infection. The challenge in delaying cranial reconstruction following craniectomy is that scalp contraction is proportionately compounded over time, reducing the scalp surface area as well as volume and complicating the ability to create a durable and tension-free primary repair. The scalp of neuro-oncology patients who have received cranial radiation is especially difficult as ionizing radiation stimulates dense fibrosis leading to scalp atrophy and devascularization, a process that delays wound healing and promotes ulcer formation. 10, 30 These challenges prompted the senior author (H.P.H.), who has had success with DermaClose RC in the closure of fasciotomies, to use this device to facilitate scalp tissue expansion in patients with large cranial defects and severe tissue retraction, which ultimately simplifies cranial reconstructions. While DermaClose RC use has been described for tissue expansion in the plastic surgery literature, 2, 11, 20, 25 there are no reports of its use for preoperative scalp tissue expansion prior to cranioplasties. The DermaClose RC device is placed circumferentially around the cranial defect, achieving tissue expansion without the need for traditional buried inflatable implants. Use of the DermaClose RC device is especially beneficial in patients with a history of soft tissue infections because, in contrast to the traditional internal tissue expanders, external scalp tissue stretch is not associated with potential contamination of the tissue planes used for the eventual cranioplasty. Other important advantages of this technique over buried implants include the following: 1) simplicity, because the device can be easily placed in an outpatient setting with the patient under local anesthesia; 2) costeffectiveness, because the device is less expensive than implanted devices; 28 3) acceleration of wound closure because the device simply stretches the tissues back to their natural dimensions and eliminates the time required for cellular growth (7-10 days as opposed to 207 days of internal tissue expansion prior to definitive closure, reported in some studies); 28 4) expeditious wound closure that allows patients to continue postoperative radiation therapy in a timely fashion; 5) eliminates the need for frequent outpatient visits for inflation, which are required for placement of traditional implantable devices; and 6) the device is well tolerated with minimal discomfort. 25 Our reported technique has several noteworthy limitations. First, excessive soft tissue expansion over the curvature of the skull, in particular with a crisscrossing pattern of tension bands, is a significant limitation of the DermaClose RC device as the tension bands could lacerate the scalp even with the addition of protective plastic sleeves. This is the primary reason why we elected to apply the tension bands circumferentially around the defect. Second, while previous investigators have been able to calculate 2D measurements such as wound surface area before and after application of an external tissue expansion system, 25 to date there are no validated reports of 3D software capable of accurately measuring the volume of expanded soft tissue after maximal scalp stretching in patients undergoing custom cranioplasty. This, coupled with the fact that our patients do not routinely undergo postcranioplasty imaging studies, forced our engineers to create a new method that calculates the volume of expanded scalp tissue based on measurements extrapolated from the unadulterated contralateral scalp as well as 3D soft-tissue renderings of each patient's head. Thus, there may be operator-dependent as well as software-dependent errors inherent in our calculations that may have under-or overestimated our final measurements. It is also important to note that a second company that supplied custom cranial implants for 3 of the patients in this study was unable to calculate scalp volumes despite employing sophisticated computer software. As a result, we could report changes in scalp volumes following the application of the DermaClose RC device in only 3 of the 6 patients. We hope that our novel approach can spark the creation of advanced software that can more easily measure scalp tissue volumes in the future.
The DermaClose RC device has broad applicability for the complex wound closures commonly seen in patients with devitalized tissues after infection, chemotherapy, and cranial radiation, as demonstrated by the patients in our series. The device's simplicity and durability obviates the need for resource-intensive and cumbersome free flaps or fragile skin grafts that are cosmetically unappealing and can be associated with greater overall risks of infection as well as higher levels of patient discomfort. 20, 23 Additionally, the DermaClose RC device is reliable, is associated with excellent cosmetic outcomes, and may prove to be more cost-effective than traditional implantable devices. Long-term prospective comparisons are necessary to determine the superiority of the DermaClose RC device over more traditional tissue expanders.
To date, no consensus guidelines exist for the management of complex cranial reconstructions, and large-scale randomized comparative studies are required to determine the efficacy of cranial reconstructions using this novel technique. However, our experience has been encouraging, and our technique has provided patients with excellent cosmetic results.
Regardless of the tissue expansion and/or mobilization technique used, the primary goal of any cranial reconstruction is to provide excellent structural and cosmetic results while minimizing morbidity. In select patients with complicating factors such as infected and discarded bone flaps, the volume generated by expensive prefabricated implants makes a primary, tension-free scalp closure even more imperative. While this series of 6 patients composes a small cohort, we believe that the reliability and technical ease of this method combined with an excellent structural success rate and the absence of morbidity in a complicated subset of patients makes the DermaClose RC device worth consideration in the reconstruction of large and complicated cranial defects.
conclusions
Reconstruction of complex cranial defects remains a challenge for plastic surgeons and neurosurgeons despite advances in bioregenerative technology and surgical techniques. The DermaClose RC external scalp tissue expander allows for simple and effective cranial reconstruction in scenarios previously fraught with high complication rates.
references
